Claire Aldridge

Claire Aldridge has a strong background in biotech and business development. Claire currently holds the role of Chief Strategy Officer at Form Bio since July 2022. Prior to this, they served as a Member of the Board of Directors at 4E Therapeutics Inc. starting in May 2022. Claire was also a Scientific Advisory Board Member at Colossal Biosciences from July 2021 onwards. Claire's previous positions include Director of Biotech at Capital Factory since January 2021 and SVP, Chief of Staff and Business Operations at Taysha Gene Therapies from July 2021 to April 2022. Claire also served as a Scientific Advisor at the Biotech+ Hub at Pegasus Park from September 2020 to April 2022. Claire's earlier experience includes roles such as AVP, Commercialization and Business Development at UT Southwestern Medical Center from April 2019 to February 2021 and VP, Venture Development at Remeditex Ventures from July 2011 to April 2019. Claire had multiple roles at UT Southwestern Medical Center, including Director of Technology Commercialization from July 2010 to July 2011 and Director of Development from October 2005 to July 2010. Before that, Claire was the Director of Strategic Alliances at Vitality, a Krames Company from January 2005 to October 2005.

Claire Aldridge holds a Doctor of Philosophy (PhD) degree in Immunology and Genetics, which they obtained from Duke University School of Medicine from 1991 to 1996. Prior to that, they completed their Bachelor of Science (BS) in Biomedical Science at Texas A&M University from 1987 to 1991.